ProVerum Medical Closes Investment Round
An investment round for ProVerum Medical has recently closed at $4.2m. This investment will help the start-up begin its first human trials for a device to treat benign prostatic hyperplasia (BHP).
Transformational Change in 13 weeks – Accelerator Teams raising €5million & creating 40 jobs this year
Ireland’s first Security Accelerator welcomed Investors, VCs and Seasoned Entrepreneurs to Cork for Demo Day where the Accelerator Teams pitched for investment. The Accelerator teams are looking to employ up to 40 people before the end of this year and raise over €5 million in investment. The Accelerator is supported by key funding partners Kernel Capital and Trend Micro.
New AnaBio Facility Opens in Carrigtwohill
Dairy Reporter - Irish company AnaBio Technologies LTD, which specializes in encapsulation using natural food proteins, opened its new facility in Carrigtwohill, near Cork, Ireland recently
Dan MacSweeney Appointed as AnaBio Chairman
Dan MacSweeney has been appointed Chairman to the Board of Directors of Anabio Technologies, his experience and strategic vision is expected to drive the company to become one of the world leaders in micro-encapsulation companies.
Venn Life Sciences acquires interest in VLSF
Read the article reporting the acquistion of minority interest in the French entity of Venn Life Sciences by the parent company. This will result in Venn Life Sciences plc having full ownership of VLSF.
HBAN National Conference – Feb 2018
HBAN (Halo Business Angel Network) plan to sign up 35 new business angel investors at their conference in Dublin on 8th February 2018.
AventaMed Heading to the US
Silicon Republic - Cork medtech firm AventaMed secures €1.8m to take grommets Stateside - Irrus Investments
Nexvet acquired by Zoetis for $85m
The Irish Times - Zoetis pays $85m for Irish petcare biopharma Nexvet Please link to the article below by Dominic Coyle which was posted in Apr 2017 by irishtimes.com/business page. Nexvet, the Irish pet pharmaceutical group, had an unusual structure, with the company conducting its drug discovery in Australia, undertaking clinical trials in the United States and Europe, and manufacturing the drugs in Ireland for sale into international markets. [...]